Stock listing

Euronext:ALCOX Nicox SA Action

Home listing (Euronext) of Nicox SA

Follow Nicox SA into a list and get an email when it puts out news.

Share price · EURONEXT:ALCOX

€0.268 EUR -0.013 (-4.8%)

Close on Nov 20, 2026

Past year -12.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.252 – €0.270 EURNov 20, 2026
Volume
200,019 sharesNov 20, 2026
Market cap
€26.47M EURAt the close on Nov 20, 2026 · price × 98.76M shares outstanding
52-week range
€0.252 – €0.569 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€47,737 EURMedian day 108,641 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Nicox SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALCOX · Home€0.268 EUR-0.013 (-4.8%)200,019€0.270€0.270€0.252€0.282Close on Nov 20, 2026
LSE:0RCQ€0.264 EUR-0.017 (-5.9%)70€0.264€0.264€0.264€0.281Close on Nov 20, 2026
Frankfurt:NXOA€0.218 EUR+0.011 (+5.3%)—€0.200€0.218€0.200€0.207Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALCOX · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.268-0.013-4.8%€0.270€0.270€0.252200,019
€0.282-0.001-0.2%€0.288€0.288€0.282228,494
€0.282-0.004-1.4%€0.286€0.289€0.28281,691
€0.286-0.001-0.3%€0.290€0.290€0.28642,063
€0.287-0.003-1.0%€0.297€0.297€0.28782,753
€0.290-0.006-2.0%€0.296€0.305€0.29071,413
€0.296+0.008+2.8%€0.294€0.310€0.293123,707
€0.288+0.001+0.3%€0.290€0.291€0.28645,382
€0.287+0.002+0.7%€0.289€0.290€0.28469,793
€0.285+0.003+0.9%€0.283€0.292€0.283128,245
€0.283+0.001+0.4%€0.282€0.290€0.28288,304
€0.282+0.000+0.2%€0.282€0.290€0.28268,479
€0.281-0.009-3.1%€0.291€0.292€0.281185,815
€0.290-0.009-3.0%€0.316€0.316€0.285136,318
€0.299-0.011-3.5%€0.313€0.324€0.295310,746
€0.3100.0000.0%€0.314€0.314€0.303121,427
€0.310-0.010-3.0%€0.301€0.318€0.30184,647
€0.320+0.019+6.1%€0.301€0.320€0.296237,207
€0.301+0.008+2.6%€0.290€0.303€0.290105,874
€0.294+0.001+0.3%€0.293€0.294€0.28750,801
€0.293-0.004-1.2%€0.293€0.297€0.28972,056
€0.296-0.007-2.3%€0.292€0.300€0.29299,872
€0.303+0.006+2.0%€0.303€0.303€0.281293,009
€0.297-0.003-1.0%€0.295€0.297€0.29382,389
€0.300+0.005+1.7%€0.300€0.300€0.29589,432
€0.295+0.005+1.7%€0.290€0.307€0.29051,334
€0.290-0.011-3.5%€0.300€0.301€0.290264,337
€0.301-0.002-0.7%€0.303€0.306€0.300100,962
€0.303-0.007-2.1%€0.310€0.312€0.303116,357
€0.309+0.014+4.7%€0.314€0.314€0.30590,645
€0.295-0.018-5.8%€0.312€0.312€0.295250,705
€0.313-0.005-1.6%€0.317€0.320€0.310223,490
€0.318-0.008-2.5%€0.327€0.327€0.316109,104
€0.326+0.005+1.4%€0.324€0.328€0.32269,781
€0.322-0.004-1.1%€0.320€0.327€0.318280,187
€0.325-0.009-2.7%€0.344€0.344€0.325114,849
€0.334-0.006-1.8%€0.335€0.344€0.332210,549
€0.340+0.006+1.6%€0.339€0.345€0.334141,180
€0.3350.0000.0%€0.335€0.338€0.33544,057
€0.335-0.003-0.9%€0.337€0.344€0.334145,907
€0.338+0.002+0.4%€0.336€0.340€0.33640,939
€0.336-0.007-2.0%€0.345€0.345€0.333106,432
€0.343+0.002+0.4%€0.341€0.347€0.341107,637
€0.342+0.006+1.6%€0.340€0.349€0.336146,455
€0.336+0.006+1.7%€0.331€0.340€0.33038,279
€0.331+0.004+1.1%€0.327€0.334€0.325149,848
€0.327-0.005-1.4%€0.338€0.338€0.327133,497
€0.332-0.004-1.0%€0.340€0.340€0.330261,240
€0.335-0.009-2.6%€0.340€0.344€0.330385,535
€0.344-0.012-3.4%€0.366€0.366€0.339492,385
€0.356-0.013-3.5%€0.370€0.370€0.356170,301
€0.369-0.007-1.9%€0.377€0.377€0.363214,565
€0.376+0.001+0.3%€0.377€0.383€0.37483,632
€0.375-0.006-1.6%€0.381€0.384€0.370294,126
€0.381-0.005-1.3%€0.386€0.388€0.381106,909
€0.386+0.002+0.4%€0.389€0.389€0.382122,798
€0.385+0.002+0.4%€0.385€0.390€0.382108,178
€0.383-0.006-1.5%€0.388€0.388€0.38159,905
€0.389+0.004+1.0%€0.388€0.390€0.38390,111
€0.385-0.005-1.2%€0.380€0.385€0.379234,776
€0.390+0.010+2.6%€0.395€0.395€0.381414,664
€0.380-0.001-0.3%€0.381€0.384€0.37997,776
€0.381-0.002-0.5%€0.385€0.385€0.380169,554
€0.3830.0000.0%€0.381€0.383€0.38183,441
€0.383-0.001-0.1%€0.382€0.384€0.38164,180
€0.383-0.001-0.3%€0.383€0.386€0.38199,045

Splits

4 splits since 2002 · EURONEXT:ALCOX · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
51-for-44Split
47-for-44Split
3-for-1Split
Ticker
Euronext:ALCOX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

All Nicox SA news

Nicox SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 33 in all · newest Oct 30, 2026 · oldest 2025
Decks
109 decks · latest Oct 30, 2026

Where Nicox SA is listed

ListingExchangeCountryCurrency
Euronext:ALCOX · Home listing · This pageEuronextFranceEUR
LSE:0RCQLSEUnited KingdomEUR
gettex:NXOAgettexGermanyEUR
LS Exchange:A143G8LS ExchangeGermanyEUR
Lang & Schwarz:A143G8Lang & SchwarzGermanyEUR
OTC:NICXFOTCUnited StatesUSD
Dusseldorf:NXOADusseldorfGermanyEUR
Aquis:ALCOXPAquisUnited KingdomEUR
Aquis:ALCOXPAquisUnited KingdomEUR
Frankfurt:NXOAFrankfurtGermanyEUR
Hamburg:NXOAHamburgGermanyEUR
Munich:NXOAMunichGermanyEUR
Stuttgart:NXOAStuttgartGermanyEUR
Turquoise:ALCOXPTurquoiseUnited KingdomEUR

Valuation

EV/sales 1.4× against a median of 50.2×: 2nd lowest of 3 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€23.40M EUR
P/E
Loss
EV/sales
1.4×
EV/EBITDA
Negative EBITDA
Price/book
3.8×
Gross margin
39.0%
Operating margin
−81.3%
Net margin
−14.4%
Debt to equity
0.4×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nicox SA · EURONEXT:ALCOXUS$29.05MUS$25.67Mn/a1.4×n/a3.8×−14.4%0.4×n/a
Pacific Software, Inc. · OTC:PFSFUS$29.86MUS$38.10Mn/an/an/an/an/an/a1.57
NextCure, Inc. · NASDAQ:NXTCUS$29.53MUS$20.81Mn/an/an/a5.4×n/a0.0×1.85
NurExone Biologic Inc · TSXV:NRXUS$29.53MUS$28.52Mn/an/an/a23.3×n/a0.0×0.00
BioHarvest Sciences, Inc. · NASDAQ:BHSTUS$29.47MUS$34.54Mn/a1.0×n/a1.8×−34.7%1.0×0.43
Thiogenesis Therapeutics Corp · TSXV:TTIUS$29.28MUS$24.21Mn/an/an/a6.2×n/a0.0×0.37
NanoViricides, Inc. · AMEX:NNVCUS$29.11MUS$26.54Mn/an/an/a4.5×n/a0.0×1.82
Rein Therapeutics, Inc. · NASDAQ:RNTXUS$29.06M−US$6.43Mn/an/an/a0.6×n/a0.0×2.11
Serina Therapeutics, Inc. · AMEX:SERUS$28.45MUS$12.42Mn/a99.3×n/a2.0×n/a0.2×1.60
ProMIS Neurosciences Inc. · NASDAQ:PMNUS$28.43M−US$15.68Mn/an/an/a0.7×n/a0.0×0.83
Entropy Neurodynamics Limited · ASX:ENPUS$28.14MUS$24.45Mn/an/an/a5.8×n/a0.0×n/a
Median of the othersUS$29.20MUS$24.33M50.2×4.5×−34.7%0.0×1.57

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
1.00 EUR · Analysts' mean
EPS, year to Dec 2026
-0.050 · 1 analyst
Revenue, year to Dec 2026
3M · 1 analyst

Team and board

Officers

OfficerRole
Gavin SpencerChief Executive Officer

Board

DirectorRole
Damian MarronChairman of the Board of Directors
Christine PlacetDirector
Gavin SpencerChief Executive Officer
Marc Le BozecDirector

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Oct 15, 2025 · Before open+4.1%
Q2 2025Sep 3, 2025−1.2%
Quarter to Mar 31, 2025Apr 30, 2025−4.7%
Quarter to Sep 30, 2024Oct 17, 2024−1.6%
Quarter to Mar 31, 2024Apr 22, 2024−0.5%
Q4 2023Jan 25, 2024 · Before open−2.4%
Quarter to Sep 30, 2023Oct 20, 2023 · Before open−0.7%
Q2 2023Jul 19, 2023 · After close+0.9%
Q1 2023Apr 19, 2023 · Before open−9.0%
Q4 2022Jan 18, 2023 · Before open−1.1%
All 18 quarters
QuarterResultsShare move
Quarter to Sep 30, 2022Oct 19, 2022+5.4%
Q2 2022Sep 16, 2022−0.3%
Quarter to Mar 31, 2022Apr 28, 2022+1.8%
Q4 2021Mar 10, 2022+3.5%
Quarter to Sep 30, 2021Oct 19, 2021+0.8%
Q2 2021Sep 27, 2021−1.2%
Quarter to Mar 31, 2021Apr 19, 2021−2.6%
Q4 2020Mar 1, 2021−1.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck26 slidesOct 30, 2026
Investor Presentation (September 2026)Investor deck28 slidesSep 11, 2026
Investor Presentation (April 2026)Investor deck25 slidesApr 30, 2026
Investor Presentation (February 2026)Investor deck25 slidesFeb 24, 2026
Investor Presentation (January 2026)Investor deck25 slidesJan 5, 2026
Investor Presentation (January 2026)Investor deck25 slidesJan 5, 2026
Investor Presentation (October 2025)Investor deck25 slidesOct 23, 2025
Investor Presentation (October 2025)Investor deck25 slidesOct 23, 2025
Investor Presentation (September 2025)Investor deck26 slidesSep 4, 2025
Investor Presentation (August 2025)Investor deck33 slidesAug 21, 2025
Show 50 decks
DeckKindSlidesDate
Investor Presentation (August 2025)Investor deck33 slidesAug 21, 2025
Investor Presentation (August 2025)Investor deck31 slidesAug 5, 2025
Investor Presentation (August 2025)Investor deck31 slidesAug 5, 2025
Investor Presentation (July 2025)Investor deck31 slidesJul 17, 2025
Investor Presentation (May 2025)Investor deck31 slidesMay 27, 2025
Investor Presentation (May 2025)Investor deck31 slidesMay 27, 2025
Investor Presentation (May 2025)Investor deck30 slidesMay 14, 2025
Investor Presentation (May 2025)Investor deck30 slidesMay 14, 2025
Investor Presentation (April 2025)Investor deck31 slidesApr 30, 2025
Investor Presentation (April 2025)Investor deck31 slidesApr 30, 2025
Investor Presentation (March 2025)Investor deck31 slidesMar 6, 2025
Investor Presentation (March 2025)Investor deck31 slidesMar 6, 2025
Investor Presentation (March 2025)Investor deck31 slidesMar 3, 2025
Investor Presentation (January 2025)Investor deck31 slidesJan 21, 2025
Investor Presentation (December 2024)Investor deck31 slidesDec 4, 2024
Investor Presentation (October 2024)Investor deck30 slidesOct 17, 2024
Investor Presentation (October 2024)Investor deck30 slidesOct 17, 2024
Investor Presentation (September 2024)Investor deck29 slidesSep 23, 2024
Investor Presentation (September 2024)Investor deck29 slidesSep 23, 2024
Investor Presentation (September 2024)Investor deck28 slidesSep 18, 2024
Investor Presentation (September 2024)Investor deck28 slidesSep 4, 2024
Investor Presentation (September 2024)Investor deck28 slidesSep 4, 2024
Investor Presentation (July 2024)Investor deck28 slidesJul 18, 2024
Investor Presentation (July 2024)Investor deck28 slidesJul 18, 2024
Investor Presentation (July 2024)Investor deck27 slidesJul 15, 2024
Investor Presentation (July 2024)Investor deck27 slidesJul 15, 2024
Investor Presentation (June 2024)Investor deck27 slidesJun 19, 2024
Investor Presentation (June 2024)Investor deck27 slidesJun 7, 2024
Investor Presentation (May 2024)Investor deck23 slidesMay 1, 2024
Investor Presentation (May 2024)Investor deck23 slidesMay 1, 2024
Investor Presentation (April 2024)Investor deck23 slidesApr 4, 2024
Investor Presentation (March 2024)Investor deck23 slidesMar 19, 2024
Investor Presentation (February 2024)Investor deck35 slidesFeb 29, 2024
Investor Presentation (February 2024)Investor deck36 slidesFeb 8, 2024
Investor Presentation (January 2024)Investor deck35 slidesJan 25, 2024
Investor Presentation (December 2023)Investor deck36 slidesDec 18, 2023
Investor Presentation (October 2023)Investor deck36 slidesOct 20, 2023
Investor Presentation (August 2023)Investor deck36 slidesAug 29, 2023
Investor Presentation (April 2023)Investor deck35 slidesApr 28, 2023
ARVO 2023Conference10 slidesApril 2023

This page holds 50 of 109 decks. Open Decks

Open Decks

Financings

RaiseDateIn US dollars
Ordinary bonds converted into convertible bonds (OCs)
Closed: €1M raised · €9.2 · Vester Finance
Dealers: Vester Finance
Buyers: Vester Finance
Apr 30, 2026US$1.17M
New shares (PACEO equity line)
Closed: €3.1M raised
Buyers: Vester Finance (up to 5,000,000 additional shares)
Jan 5, 2026US$3.61M
Convertible bonds
Closed: €3M raised · Vester Finance
Dealers: Vester Finance
Buyers: Vester Finance
Use of proceeds: Reinforce cash position and better manage resources
Jan 5, 2026US$3.51M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue16.8M7.86M6.90M3.27M7.23M12.9M4.72M15.1M16.0K
Cost of revenue10.2M1.11M18.4M18.0M17.9M12.7M826.0K12.9M
Gross profit6.54M6.75M-11.5M-14.7M-10.7M179.0K3.89M2.13M16.0K
Research and development5.96M7.55M18.0M17.9M12.7M17.7M16.3M9.75M12.2M
Selling, general and administrative4.23M2.94M6.76M6.34M6.03M6.59M9.51M9.87M8.62M
Operating income-13.6M-9.85M-17.1M-34.1M-46.0M-6.76M-18.3M-21.8M-17.6M-20.8M
Depreciation and amortization9.69K17.2K21.5K11.2M29.4M1.74M1.12M136.0K171.0K220.0K
EBITDA-13.6M-9.84M-17.0M-22.8M-16.6M-5.02M-17.2M-21.7M-17.4M-20.6M
Interest expense2.95M1.56M1.63M2.14M4.85M12.5M5.09M71.0K18.0K107.0K
Income before tax-2.41M-22.1M-21.4M-30.3M-47.4M-18.1M-19.1M-19.7M-6.69M
Income tax-12259.4K-477.8K-3.03M-3.64M28.0K-727.0K-11.4M52.0K
Net income-2.41M-22.4M-20.9M-31.3M-43.8M-18.1M-18.9M-18.4M-3.62M-19.0M
Earnings per share, basic-0.03-0.45-0.42-0.62-117.00-54.00-0.56-0.62-0.13-0.80

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.15M10.5M11.3M27.1M42.0M47.2M22.1M41.4M28.9M
Receivables3.20M9.95M37.7M40.5M1.09M1.72M1.07M616.0K44.0K104.0K
Current assets10.2M23.7M51.1M33.7M47.7M52.5M26.1M44.3M30.7M
Property, plant and equipment11.0K26.0K240.0K1.02M1.17M
Goodwill00027.2M25.6M23.7M25.8M25.4M24.2M27.5M
Total assets10.4M24.4M53.0M93.2M114.6M142.3M138.6M150.8M148.7M
Accounts payable675.5K1.65M2.50M2.54M3.65M2.42M5.00M4.28M1.93M1.34M
Current liabilities2.45M3.57M5.07M7.64M8.00M15.4M2.48M8.07M7.98M13.4M
Long-term debt15.1M25.2M20.0M21.2M13.4M
Total debt406.3K17.7M25.2M26.5M21.5M19.1M85.0K50.0K62.0K
Total liabilities4.35M21.0M31.6M40.7M39.1M41.4M15.4M24.9M24.0M44.2M
Shareholders' equity6.02M3.41M21.4M42.3M75.6M100.8M113.7M126.8M104.5M
Shares outstanding88.1M49.9M49.9M50.1M43.1M37.0M33.7M29.6M27.0M23.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-23.1M-18.5M-5.39M-16.1M-19.1M-12.4M-25.7M
Capital spending000-42.0K-8.00K-20.0K-95.0K-228.0K-77.0K-8.00K
Free cash flow-23.2M-18.5M-5.41M-16.1M-19.4M-12.5M-25.7M
Cash from investing132.0K-175.0K4.95M-95.0K-270.0K60.0K8.82M
Cash from financing8.64M13.4M19.6M22.2M25.1M16.7M
Share buybacks9.18M-91.0K-633.0K-20.0K
Change in cash-27.6M-14.3M-5.25M19.1M6.04M-19.3M12.5M-211.0K

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from Nicox SA’s releases · as of Apr 30, 2026

Common shares
98,757,645
Fully diluted
98,757,645

Fully diluted

LineShares
Common shares98,757,645

Share count over time

CountShares
Nov 22, 202698,757,645

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christine PlacetDirector · Since at least Nov 5, 2026
Damian MarronChairman of the Board of Directors · Since at least Nov 5, 2026
Gavin SpencerChief Executive Officer · Since at least Jul 1, 2026
Marc Le BozecDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Nicox SA.